The proportion of TiNK cells averaged 18% (range 1.8% to 36.8%) of the total CD45+ population (Table 1), which is consistent with previous reports of RCC tumors being infiltrated by lymphocytes, including NK cells [13–15]. This evidence concerns the gene PTPRC and renal cell carcinoma.